Regocent40mg
Rx- Generic:
- Regorafenib Monohydrate
- Company:
- Incepta Pharmaceuticals Ltd.
- Dosage form:
- Tablet
- Pack size:
- Box (10 Tablet)
Save to my medicines
Alert me on price drop
৳ 200/unit
Pack: ৳ 2,000
At a glance
Regorafenib is a multi-kinase inhibitor used for metastatic colorectal cancer (CRC), locally advanced unresectable or metastatic gastrointestinal stromal tumor (GIST), and hepatocellular carcinoma (HCC) after prior therapy failure.
Indications
- Metastatic colorectal cancer (after fluoropyrimidine, oxaliplatin, irinotecan-based chemotherapy, anti-VEGF therapy, and anti-EGFR therapy for RAS wild-type)
- Locally advanced unresectable or metastatic GIST (after imatinib and sunitinib)
- Hepatocellular carcinoma (after sorafenib)
Dosage
Adult Dose (Oral):
- Recommended dose: 160 mg (four 40 mg tablets) once daily for the first 21 days of each 28-day cycle
- Take with a low-fat meal (<600 calories, <30% fat) and swallow whole with water
- Dose modifications: Reduce in 40 mg increments; lowest recommended dose 80 mg daily
Side effects
Side Effects:
- Hepatotoxicity
- Infections
- Hemorrhage
- Gastrointestinal perforation or fistula
- Hand-foot skin reaction (HFSR)
- Hypertension
- Cardiac ischemia and infarction
- Reversible Posterior Leukoencephalopathy Syndrome (RPLS)
Precautions & warnings
- Hepatotoxicity: Monitor LFT every 2 weeks during first 2 months; withhold, reduce, or discontinue for severe toxicity
- Hemorrhage: Permanently discontinue for severe or life-threatening hemorrhage; monitor INR in patients on warfarin
- GI perforation/fistula: Permanently discontinue
- Hypertension: Control blood pressure; monitor weekly for first 6 weeks
- Wound healing: Discontinue at least 2 weeks before surgery
- Embryo-fetal toxicity: Use effective contraception
⚠️ This information is for educational purposes only — not a substitute for medical advice. Consult a registered physician before taking any medicine.